Clinical Trial Update: M7824 and Topotecan or Temozolomide in Relapsed Small Cell Lung Cancers [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating M7824 (bintrafusp alfa) in combination with Topotecan or Temozolomide for relapsed small cell lung cancer. The study has completed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• M7824 (bintrafusp alfa)
• Temozolomide (Temozolomide)
• Topotecan (topotecan)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Carcinoma, Small Cell, Lung Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-05-09